Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01572272
Other study ID # D007157
Secondary ID
Status Completed
Phase N/A
First received March 25, 2012
Last updated November 1, 2016
Start date August 2012
Est. completion date February 2015

Study information

Verified date November 2016
Source Medtronic - MITG
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

Primary:

The purpose of this study is to assess the clinical implications of continuous distal CO2 monitoring when used for clinical decisions

Sub Study:

• Evaluate the average life time (duration) of Standard Carinal VitaLine set in comparison to the Carinal VitaLine set that its sampling tubing is made of PEBAX (dehumidifying material).

Description of Study Design:

Patients will be randomized at the baseline evaluation visit into one of the following groups:

- Masked group: Data derived from the Capnostream20p will be recorded; however the medical staff will be masked from it and hence will not use it.

- Open group: Data derived from the Capnostream20p and displayed to the medical team. It will allow the treating physician and the nursing team to review the real time data and make clinical decisions based upon it if felt necessary.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Intubated neonates with double-lumen ETT (Uncuffed Tracheal Tube, Mallinckrodt Inc., Chih, Mexico) that their respiratory condition requires conventional ventilation.

- Obtaining signed Informed Consent Form by the parents or legal guardian

- Intubated neonates that are expected to provide at least 3 pairs of blood samples and ETCO2 measurements during ventilation period

Exclusion Criteria:

- Intubated neonates with single-lumen ETTs

- Neonates who are ventilated with HFV

- Any significant medical condition which, at the investigator's discretion, may interfere with the study.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Intubated Neonates That Require Conventional Ventilation

Locations

Country Name City State
Israel Soroka MC Beer Sheva
Israel Bnai Zion MC Haifa
Israel Shaare Zedek MC Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Oridion

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare between the open and the masked group in the following: the percentage of measurement points at the Safe range: 60>PaCO2>30, Normal range 45>PaCO2>35 and Adequate (permissive) range: 45-55. Participants will be follwed throughout the duration of the ventilation. Estimated time: 14 days 2 weeks No